About Ocelot Bio
Ocelot Bio is a private company based in San Diego, California, incorporated in 2020 in Delaware. It has reported $39,000,007 raised in two offerings on Form D since April 2021. Its chief executive is Katherine Stultz.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 6, 2023 | Jul 13, 2023 | $3,000,000of $12.0M target | 5 | $600K | DebtRule 506(b) | Form D ↗ |
| Mar 31, 2021 | Apr 15, 2021 | $36,000,007of $38.0M target | 5 | $7.2M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $39,000,007 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Ocelot Bio's Form D filed Jul 13, 2023.
CS
Camille Samuels
Director
DS
Donald Santel
Director
JN
Jack Nielsen
Director
KS
Katherine Stultz
President and Chief Executive Officer, director
JS
Jennifer Schranz
Director
Earlier filings also listed Geoffrey Harris (executive officer and director, last listed Apr 2021).